Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment

Published:2021 Issue:6 Volume:9 Page:2279-2294
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Chen Ranran¹²³⁴^ORCID,Huang Yuanjian¹⁵²³⁴,Wang Lu¹²³⁴,Zhou Jiahui¹²³⁴,Tan Yuqian¹²³⁴,Peng Chaofan¹²³⁴,Yang Peng¹²³⁴,Peng Wen¹⁵²³⁴,Li Jie¹²³⁴,Gu Qiou¹²³⁴,Sheng Yuchen⁶⁷⁸⁹⁴,Wang Yan⁶⁷⁸⁹⁴,Shao Guoqiang¹⁰¹¹⁸¹²⁴^ORCID,Zhang Qing⁶⁷⁸⁹⁴,Sun Yueming¹⁵²³⁴

Affiliation:

1. Department of General Surgery

2. The First Affiliated Hospital of Nanjing Medical University

3. Nanjing 210029

4. China

5. Colorectal Center

6. Department of Pharmaceutics

7. School of Pharmacy

8. Nanjing Medical University

9. Nanjing 211166

10. Department of Nuclear Medicine

11. Nanjing First Hospital

12. Nanjing 210006

Abstract

The CTX-SLB-MSN targeted nanoplatform has a substantial potential in combinational therapy against colorectal cancer.

Funder

National Key Research and Development Program of China

Jiangsu Provincial Medical Youth Talent

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D0BM01904F

Reference55 articles.

1. Colorectal cancer

2. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies

3. Comprehensive review of targeted therapy for colorectal cancer

4. Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer

5. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Ferritin Nanocarriers with ICG for Effective Phototherapy Against Breast Cancer;International Journal of Nanomedicine;2024-05

2. Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy;Journal of Nanobiotechnology;2024-04-15

3. Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristics;Oral Oncology;2024-02

4. LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy;International Journal of Nanomedicine;2024-02

5. Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer;AAPS PharmSciTech;2024-01-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3